gBRCA1/2 mutations increase the incidence of breast cancer (BC) by interrupting the homologous recombination repair (HRR) pathway. Although gBRCA1 and gBRCA2 BC have similar clinical profiles, differe
Filtered variant call format (VCF) data of Jinbuol (JBO, female), Samgwang (SG, male), two RIL individuals (JSRIL1 and JSRIL2), Nipponbare1, IndicaHR12, Kitaake, and Kasalath using resequencing data p
Cancer is a genetic disease caused by an accumulation of mutations, however many of these mutations have been identified in pathologically normal tissue. We aim to use laser-capture microscopy (LCM) t
